BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11895152)

  • 1. Pyruvate kinase type M2: a crossroad in the tumor metabolome.
    Mazurek S; Grimm H; Boschek CB; Vaupel P; Eigenbrodt E
    Br J Nutr; 2002 Jan; 87 Suppl 1():S23-9. PubMed ID: 11895152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.
    Eigenbrodt E; Reinacher M; Scheefers-Borchel U; Scheefers H; Friis R
    Crit Rev Oncog; 1992; 3(1-2):91-115. PubMed ID: 1532331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor metabolome.
    Mazurek S; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):1149-54. PubMed ID: 12820363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
    Mazurek S
    Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply.
    Spoden GA; Rostek U; Lechner S; Mitterberger M; Mazurek S; Zwerschke W
    Exp Cell Res; 2009 Oct; 315(16):2765-74. PubMed ID: 19563799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyruvate kinase type M2 and its role in tumor growth and spreading.
    Mazurek S; Boschek CB; Hugo F; Eigenbrodt E
    Semin Cancer Biol; 2005 Aug; 15(4):300-8. PubMed ID: 15908230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7.
    Mazurek S; Zwerschke W; Jansen-Dürr P; Eigenbrodt E
    Oncogene; 2001 Oct; 20(47):6891-8. PubMed ID: 11687968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours.
    Mazurek S
    Ernst Schering Found Symp Proc; 2007; (4):99-124. PubMed ID: 18811055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.
    Mazurek S; Zwerschke W; Jansen-Dürr P; Eigenbrodt E
    Biochem J; 2001 May; 356(Pt 1):247-56. PubMed ID: 11336658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism.
    Mazurek S; Drexler HC; Troppmair J; Eigenbrodt E; Rapp UR
    Anticancer Res; 2007; 27(6B):3963-71. PubMed ID: 18225557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria, hexokinase and pyruvate kinase isozymes in the aerobic glycolysis of tumor cells.
    Petrucci D; Cesare P; Colafarina S
    Ital J Biochem; 1997 Sep; 46(3):131-41. PubMed ID: 9442422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas.
    Eigenbrodt E; Basenau D; Holthusen S; Mazurek S; Fischer G
    Anticancer Res; 1997; 17(4B):3153-6. PubMed ID: 9329624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-analytical problems in the measurement of tumor type pyruvate kinase (tumor M2-PK).
    Oremek GM; Gerstmeier F; Sauer-Eppel H; Sapoutzis N; Wechsel HW
    Anticancer Res; 2003; 23(2A):1127-30. PubMed ID: 12820359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus.
    Koss K; Harrison RF; Gregory J; Darnton SJ; Anderson MR; Jankowski JA
    J Clin Pathol; 2004 Nov; 57(11):1156-9. PubMed ID: 15509675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.
    Kumar Y; Tapuria N; Kirmani N; Davidson BR
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):265-76. PubMed ID: 17301655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death.
    Steták A; Veress R; Ovádi J; Csermely P; Kéri G; Ullrich A
    Cancer Res; 2007 Feb; 67(4):1602-8. PubMed ID: 17308100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate kinase isoenzyme M2 is not of diagnostic relevance as a marker for oral cancer.
    Ervens J; Fuchs H; Niemann VT; Hoffmeister B
    J Craniomaxillofac Surg; 2008 Mar; 36(2):89-94. PubMed ID: 18243718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors.
    Eigenbrodt E; Kallinowski F; Ott M; Mazurek S; Vaupel P
    Anticancer Res; 1998; 18(5A):3267-74. PubMed ID: 9858894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on associations of glycolytic and glutaminolytic enzymes in MCF-7 cells: role of P36.
    Mazurek S; Hugo F; Failing K; Eigenbrodt E
    J Cell Physiol; 1996 May; 167(2):238-50. PubMed ID: 8613464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pfl gene knockout on the metabolism for optically pure D-lactate production by Escherichia coli.
    Zhu J; Shimizu K
    Appl Microbiol Biotechnol; 2004 Apr; 64(3):367-75. PubMed ID: 14673546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.